To start with, the relation between differential expression of FARSB in hepatocellular carcinoma and patients’ poor prognosis was explored, and included the mechanism of FARSB in liver cancer, such as tumor infiltrating immune cells, m6a methylation and drug sensitivity. The gene discussed is FARSB; the disease is liver cancer.